LadRx (STU:CX5) Market Cap : €1.42 Mil (As of May. 16, 2024)

View and export this data going back to 1986. Start your Free Trial

What is LadRx Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). LadRx's share price for the quarter that ended in Dec. 2023 was €0.056. LadRx's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 0.50 Mil. Therefore, LadRx's market cap for the quarter that ended in Dec. 2023 was €0.03 Mil.

LadRx's quarterly market cap stayed the same from Jun. 2023 (€0.03 Mil) to Sep. 2023 (€0.03 Mil) and stayed the same from Sep. 2023 (€0.03 Mil) to Dec. 2023 (€0.03 Mil).

LadRx's annual market cap declined from Dec. 2021 (€0.16 Mil) to Dec. 2022 (€0.04 Mil) and declined from Dec. 2022 (€0.04 Mil) to Dec. 2023 (€0.03 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. LadRx's Enterprise Value for Today is €-0.46 Mil.

LadRx Market Cap Historical Data

The historical data trend for LadRx's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LadRx Market Cap Chart

LadRx Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

0.08

0.50

0.16

0.04

0.03

LadRx Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial															0.04	0.03	0.03	0.03	0.03

Competitive Comparison of LadRx's Market Cap

For the Biotechnology subindustry, LadRx's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LadRx's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LadRx's Market Cap distribution charts can be found below:

* The bar in red indicates where LadRx's Market Cap falls into.

LadRx Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

LadRx's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	€0.056	*	0.49509
	=	€0.03

LadRx's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	€0.056	*	0.49509
	=	€0.03

LadRx (STU:CX5) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

LadRx Market Cap Related Terms

Thank you for viewing the detailed overview of LadRx's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

LadRx (STU:CX5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LadRx Corp (STU:CX5) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

LADX:USA

Address

11726 San Vicente Boulevard, Suite 650, Los Angeles, CA, USA, 90049

Website

https://www.ladrxcorp.com

LadRx Corp operates as a biopharmaceutical research and development company in the healthcare sector of the United States. It is focused on the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company develops Aldoxorubicin, which is meant to cure soft tissue sarcoma, a kind of tumor. It also develops Arimoclomol which is in development in Niemann Pick disease Type C (NPC) and Gaucher disease.

LadRx (STU:CX5) Headlines

No Headlines